BARER SOL J 4

4 · NexImmune, Inc. · Filed Apr 6, 2023

Form 4

Period: 2023-04-04

Director

Transactions

Award
Stock Option (right to buy)
2023-04-04+61,678→ 61,678 total
Exercise: $1.64Exp: 2032-06-12→ Common Stock (61,678 underlying)
Disposition to Issuer
Stock Option (right to buy)
2023-04-04−19,113→ 0 total
Exercise: $17.00Exp: 2031-02-10→ Common Stock (19,113 underlying)
Disposition to Issuer
Stock Option (right to buy)
2023-04-04−61,678→ 0 total
Exercise: $1.82Exp: 2032-06-12→ Common Stock (61,678 underlying)
Disposition to Issuer
Stock Option (right to buy)
2023-04-04−155,900→ 0 total
Exercise: $5.17Exp: 2030-03-04→ Common Stock (155,900 underlying)
Award
Stock Option (right to buy)
2023-04-04+155,900→ 155,900 total
Exercise: $1.64Exp: 2030-03-04→ Common Stock (155,900 underlying)
Award
Stock Option (right to buy)
2023-04-04+19,113→ 19,113 total
Exercise: $1.64Exp: 2031-02-10→ Common Stock (19,113 underlying)

Footnotes (3)

[F1]The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on June 13, 2022, of which all of the shares subject to such option will vest on June 13, 2023, subject to Mr. Barer's continued service on such vesting date.
[F2]The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 11, 2021, of which all of the shares subject to such option have vested.
[F3]The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on March 5, 2020, of which all of the shares subject to such option have vested. Mr. Barer has exercised his right to purchase 50,000 shares subject to the original option.

Documents

1 file